Renovaro is expanding the ongoing strategic collaboration with Nebul to advance the early detection of cancer and other diseases. The partnership aims to leverage Renovaro’s deep learning and ML programs with Nebul’s high-performance computing built on the latest platform to accelerate biomarker discovery and next-generation diagnostics.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RENB:
- Renovaro BioSciences, BioSymetrics close merger transaction
- China announces retaliatory tariffs, U.S. unemployment rises: Morning Buzz
- Renovaro says Predictive Oncology terminates merger transaction
- Renovaro BioSciences provides update to agreement with Predictive Oncology
- Renovaro says Predictive Oncology terminated merger agreement